Preview

Pharmaceutical Marketing

Powerful Essays
Open Document
Open Document
7563 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Pharmaceutical Marketing
Pharmaceutical Marketing
Merck
“Merck has gone beyond developing and selling prescription pharmaceuticals. It formed joint ventures in 1989 with Johnson & Johnson to sell over the-counter pharmaceuticals; in 1991 with DuPont to expand basic research, and in 2000 with Scherigng-Plough to develop and market new prescriptions medicines. In 1997, Merck and Rhone-Poulenc S.A. (now Sanofi-Aventis S.A.) combined animal health and poultry genetics business to form Merial Limited, a fully integrated animal health company. Finally, Merck purchased Medco, a mail –order pharmaceutical distributor, in 2003, and Sirna Therapeutics in 2006” (Kotler & Keller, 2012, p. 43-44).
“For branding strategies to be successful and brand value to be created, consumers must be convinced there are meaningful differences among brands in the product or service category. Brand differences often related to attributes or benefits of the product itself . . Merck has lead (its) product categories for decades, due in part to continual innovation” (Kotler & Keller, 2012, p. 243).
Merck has donated $100 million or more to charities in a year (Kotler & Keller, 2012, p. 632).

Mission Statements
Ex. Japan
Both pharmaceutical and biotech companies are starting to make partnership a core competency (Kotler & Keller, 2012, p. 52).

Intro:
Michael Dawson, author of “The Consumer Trap,” states that the business of marketing, a trillion-dollar –a-year industry, is a social, economical, environmental, and unfriendly cost on Americans today as it “continues to soak up economic and environmental resources and dominate the personal lives of citizens” (Dawson, 2005, p. 1). Dawson argues that corporate America is fueled by a continuous marketing race that manipulates people’s perceptions and actions of goods into thinking the economy is out to serve one’s pleasures and happiness, when in all reality, is only out to serve the demand of business today (Dawson, 2005, p. 1).



References: Dawson, M. (2005). The Consumer Trap. University of Illinois Press. Retrieved from: http://www.press.uillinois.edu/books/catalog/55khc7bf9780252072642.html Deutsches Aerzteblatt International (2010, May 9) Need of New Pharmaceutical Marketing Strategies (2010, March, 23). Pharmaceutical & Drug Manufacturer Resources. Retrieved from: http://www.pharmaceutical-drug-manufacturers.com/articles/marketing-strategy.html Saul, S

You May Also Find These Documents Helpful

  • Satisfactory Essays

    Fi561 You Decide

    • 430 Words
    • 2 Pages

    I’m concerned about synergy and integration issues between our highly research-oriented development of pharmaceuticals here at Merck, and a prescription medicine marketing company like Medco. I am concerned that the cultures and operations of the two companies aren’t going to mix well, and that this deal would result in an expensive failure.…

    • 430 Words
    • 2 Pages
    Satisfactory Essays
  • Better Essays

    Harris, Gardiner. “Pfizer Pays $2.3 Billion to Settle Marketing Case” NY Times. September 2, 20009.…

    • 958 Words
    • 4 Pages
    Better Essays
  • Powerful Essays

    Merck is a well-run company with advanced in-house R&D capabilities. Although the company is not completely admonished from faltering performances by its competitors, many believe this offsets any setbacks from strong sales of new product approvals like Victrelis as well as cost- cutting efforts.…

    • 1517 Words
    • 7 Pages
    Powerful Essays
  • Satisfactory Essays

    Docwra's book provides frank views on the course consumerism has put the society on. Docwra takes a serious approach to the aspects of consumerism, the sections in Docwra's book are at first problematic and situational but then become rectifying and provides direction on everything from the effects of consumerism to what is wrong with consumerism resulting in what can we do about consumerism. Docwra informs us on the negative effects consumerism places upon us, but Docwra puts most attention into providing tactics we can use to stop consumerism. He states: "To move away from a culture of consumerism, we will therefore need to challenge the philosophy and values of this current economic system. Essentially, we need a cultural shift in our society…

    • 262 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Bmgt496

    • 745 Words
    • 3 Pages

    Back in 2005, Merck was described as a unique force in the pharmaceutical industry; its leadership in profits, sales, assets, and market value was recognized by investors and respected by competitors. Society in general had a favorable reception for the company due to their different acts of generosity, like the eternal donation of Mectizan to patients suffering of red blindness. In addition, the company has demonstrated high ethical standards together with high levels of responsibility to society positioning the company in a privileged position where professionals and consumers where equally please.…

    • 745 Words
    • 3 Pages
    Good Essays
  • Satisfactory Essays

    The following information was taken from the 2006 financial statements of pharmaceutical giant Merck and Co. All dollar amounts are in millions.…

    • 310 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Pfizer Inc. is a large pharmaceutical company that engages in the discovery of new technologies, the manufacture of prescription and "over the counter" (OTC) medicines, as well as the marketing of such products. It operates in three distinct segments that include Human Health, Consumer Healthcare, and Animal Health. For fiscal year 2004, the company generated approximately $53 billion in revenue that contributed to over $11 billion in net income. (Pfizer, 2004)…

    • 1018 Words
    • 5 Pages
    Good Essays
  • Good Essays

    Merck's Culture

    • 435 Words
    • 2 Pages

    “May 5, 2005. It was the darkest hour in the pharmaceutical giant 's 114-year history. Merck was drowning in liability suits stemming from Vioxx, its $2.5 billion-a-year arthritis drug, which it had to pull from the market because of a link to heart attacks and strokes. Two other blockbusters worth a combined $7 billion in annual sales were facing patent expirations. And Merck 's labs, which other companies once hailed as a bastion of scientific innovation, were crippled by a culture that buried good ideas under layers of bureaucracy. But in the morass, Clark saw opportunity (www.businessweek.com).”…

    • 435 Words
    • 2 Pages
    Good Essays
  • Good Essays

    Brand and River Blindness

    • 565 Words
    • 3 Pages

    As a company that produces drugs to cure diseases in both humans and animals, Merck operates in a complex dynamic that requires it to take decisions that may not lead to profitability. Further, its corporate philosophy always revolved around the fact that the company’s first priority was the safety of people and only then did profits follow. I, therefore, believe that Merck should invest a large amount ( ~80%) of its research budget even on drugs that will produce a substandard ROI, provided the drugs promise to fully cure diseases without harmful side effects and they are the first in the market to do so. This could help them build a strong brand equity, goodwill and reputation in the long run thereby creating a foundation for profitability in future. For instance, I believe that Merck has a social responsibility and a moral obligation to invest heavily in the cure for River…

    • 565 Words
    • 3 Pages
    Good Essays
  • Satisfactory Essays

    Drug Companies and Ethics

    • 656 Words
    • 3 Pages

    Merck is one of the largest and most profitable drug companies in the world, but they have also been a leader in a donation program that helps Third World countries in Africa, South America and Yemen since the 1980’s.…

    • 656 Words
    • 3 Pages
    Satisfactory Essays
  • Good Essays

    Consumerism is supposed to offer people the promise of choice and freedom, but this is only true for an enabled portion of society, those who are able to participate effectively or those Bauman named the Seduced (Making Social Lives, 2009, p.26). These are the affluent, employed, young members of our society who are seen as socially acceptable. With this acceptance and their disposable income to consume effectively, their choices are widened. They are able to…

    • 774 Words
    • 4 Pages
    Good Essays
  • Better Essays

    Merck & Co

    • 1066 Words
    • 5 Pages

    Merck had a 14% increase in sales between 1997 and 1998 and 22% increase in sales from 1998 – 1999, and a 13% annual increase in earnings over the same period. Merck’s business strategy consists of two parts: (1) developing and marketing new drugs through internal research, and (2) developing partnerships with smaller biotechnology companies. Since 1995, Merck had launched 15 new products that earned $5.9 billion on sales of $32.7 billion. Furthermore, Merck may agree to license new drugs from other firms and with its larger capital and greater assets, can assume the risk of submitting the drug through various regulatory approval phases. If the drug becomes profitable, Merck can earn significant cash flows while paying a royalty to the licensor. However, most important is the option that Merck has in deciding when to abandon or continue on this project (deferability or optionality). If Merck reaches a point when its expected NPV is negative, it can simply abandon the project.…

    • 1066 Words
    • 5 Pages
    Better Essays
  • Powerful Essays

    Pharmaceutical Advertising

    • 2279 Words
    • 10 Pages

    In the past, the marketing of prescription drugs was mainly targeted at health care professionals so they could consult with patients and make informed decisions about prescribing new medications. However, in the 1990s, pharmaceutical drug companies started using new marketing strategies, and in addition to targeting health care professionals, they turned their attention towards patients. The industry’s new market strategy: advertise prescription drugs directly to consumers. This kind of promoting, technically known as direct-to-consumer advertising (DTCA), soon became the main focus for the U.S. pharmaceutical industry to increase its sales and profits. Soon enough every major drug company was using direct-to-consumer advertising because of the dramatic results it produced and it played a key role in competing with other companies in the industry. In addition, in 1997 the U.S. Food and Drug Administration relaxed restrictions on…

    • 2279 Words
    • 10 Pages
    Powerful Essays
  • Best Essays

    Merck and River Blindness

    • 2252 Words
    • 10 Pages

    The ethical dilemma represented by this situation is focused on what course of action Merck should take. Does Merck invest precious resources (both time and money) into testing and developing a drug that will not increase their profits? Or should Merck invest the resources knowing that their work, while not profitable, has the potential to save millions of lives and end the suffering of tens of millions more?…

    • 2252 Words
    • 10 Pages
    Best Essays
  • Good Essays

    Merck Case

    • 587 Words
    • 4 Pages

    Merck had a 14% increase in sales between 1997 and 1998 and 22% increase in sales from 1998 – 1999, and a 13% annual increase in earnings over the same period. Merck’s business strategy consists of two parts: (1) developing and marketing new drugs through internal research, and (2) developing partnerships with smaller biotechnology companies. Since 1995, Merck had launched 15 new products that earned $5.9 billion on sales of $32.7 billion. Furthermore, Merck may agree to license new drugs from other firms and with its larger capital and greater assets, can assume the risk of submitting the drug through various regulatory approval phases. If the drug becomes profitable, Merck can earn significant cash flows while paying a royalty to the licensor. However, most important is the option that Merck has in deciding when to abandon or continue on this project (deferability or optionality). If Merck reaches a point when its expected NPV is negative, it can simply abandon the project. As a licensee, Merck can allow smaller biotechnology firms to focus on research and development. These smaller firms often have smaller budgets and are not financially or personnel equipped to handle the costly and long FDA approval process, and the subsequent marketing, distribution, and sales of new drugs. This task is better suited for a larger company, such as Merck, which has more resources and money.…

    • 587 Words
    • 4 Pages
    Good Essays